首站-论文投稿智能助手
典型文献
Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases:therapeutic effects and molecular mechanisms
文献摘要:
Artemisinin and its derivatives are the well-known anti-malarial drugs derived from a traditional Chinese medicine.In addition to antimalarial,artemisinin and its derivatives possess distinguished anti-cancer,anti-oxidant,anti-inflammatory and anti-viral activities,but the poor solubility and low bioavailability hinder their clinical application.In the last decades a series of new water-soluble and oil-soluble derivatives were synthesized.Among them,we have found a water-soluble derivativeβ-aminoarteether maleate(SM934)that exhibits outstanding suppression on lymphocytes proliferation in immunosuppressive capacity and cytotoxicity screening assays with 35-fold higher potency than dihydroartemisinin.SM934 displays significant therapeutic effects on various autoimmune and inflammatory diseases,including systemic lupus erythematosus,antiphospholipid syndrome nephropathy,membranous nephropathy,rheumatoid arthritis,multiple sclerosis,inflammatory bowel disease,and dry eye disease.Here,we summarize the immunomodulatory effects,anti-inflammatory,anti-oxidative and anti-fibrosis activities of SM934 in disease-relevant animal models and present the probable pharmacological mechanisms involved in its therapeutic efficacy.This review also delineates a typical example of natural product-based drug discovery,which might further vitalize natural product exploration and development in pharmacotherapy.
文献关键词:
作者姓名:
Xiao Tong;Li Chen;Shi-jun He;Jian-ping Zuo
作者机构:
Laboratory of Immunopharmacology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China
引用格式:
[1]Xiao Tong;Li Chen;Shi-jun He;Jian-ping Zuo-.Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases:therapeutic effects and molecular mechanisms)[J].中国药理学报(英文版),2022(12):3055-3061
A类:
Artemisinin,SM934,aminoarteether,vitalize
B类:
treatment,autoimmune,inflammatory,diseases,therapeutic,effects,molecular,mechanisms,derivatives,are,well,known,drugs,derived,from,traditional,Chinese,medicine,In,addition,antimalarial,possess,distinguished,cancer,oxidant,viral,activities,but,poor,solubility,low,bioavailability,hinder,their,clinical,application,last,decades,series,new,water,soluble,oil,were,synthesized,Among,have,found,maleate,that,exhibits,outstanding,suppression,lymphocytes,proliferation,immunosuppressive,capacity,cytotoxicity,screening,assays,fold,higher,potency,than,dihydroartemisinin,displays,significant,various,including,systemic,lupus,erythematosus,antiphospholipid,syndrome,nephropathy,membranous,rheumatoid,arthritis,multiple,sclerosis,bowel,dry,eye,Here,summarize,immunomodulatory,oxidative,fibrosis,relevant,animal,models,present,probable,pharmacological,involved,efficacy,This,review,also,delineates,typical,example,natural,product,discovery,which,might,further,exploration,development,pharmacotherapy
AB值:
0.617024
相似文献
Low-dose chloroquine treatment extends the lifespan of aged rats
Wei Li;Zhiran Zou;Yusheng Cai;Kuan Yang;Si Wang;Zunpeng Liu;Lingling Geng;Qun Chu;Zhejun Ji;Piu Chan;Guang-Hui Liu;Moshi Song;Jing Qu;Weiqi Zhang-Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China;Sino-Danish Center for Education and Research,Beijing 101408,China;Chongqing Renji Hospital,University of Chinese Academy of Sciences,Chongqing 400062,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。